FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $730,000 | +9.4% | 219,400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $667,000 | +27.5% | 219,400 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $523,000 | -36.5% | 219,400 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $823,000 | +4.6% | 219,400 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $787,000 | -37.4% | 219,400 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $1,257,000 | +14.4% | 219,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,099,000 | -2.3% | 219,400 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,125,000 | -14.6% | 219,400 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $1,318,000 | +8.2% | 219,400 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $1,218,000 | +19.6% | 219,400 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $1,018,000 | -6.3% | 219,400 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $1,086,000 | -55.4% | 219,400 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $2,435,000 | +19.8% | 219,400 | 0.0% | 0.00% | +33.3% |
Q3 2016 | $2,032,000 | +45.9% | 219,400 | 0.0% | 0.00% | +50.0% |
Q2 2016 | $1,393,000 | -2.6% | 219,400 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $1,430,000 | -19.7% | 219,400 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,780,000 | +10.7% | 219,400 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,608,000 | -17.2% | 219,400 | +15.8% | 0.00% | 0.0% |
Q2 2015 | $1,942,000 | – | 189,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|